These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 23529798)
21. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients. Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566 [TBL] [Abstract][Full Text] [Related]
22. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis. Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141 [TBL] [Abstract][Full Text] [Related]
23. Oncogenic reg IV is a novel prognostic marker for glioma patient survival. Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma. Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767 [TBL] [Abstract][Full Text] [Related]
25. Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas. Feng F; Kuai D; Wang H; Li T; Miao W; Liu Y; Fan Y Hum Pathol; 2016 Dec; 58():47-53. PubMed ID: 27569294 [TBL] [Abstract][Full Text] [Related]
26. Identification of microRNA-205 as a potential prognostic indicator for human glioma. Hou SX; Ding BJ; Li HZ; Wang L; Xia F; Du F; Liu LJ; Liu YH; Liu XD; Jia JF; Li L; Wu ZL; Zhao G; Zhang ZG; Deng YC J Clin Neurosci; 2013 Jul; 20(7):933-7. PubMed ID: 23683741 [TBL] [Abstract][Full Text] [Related]
27. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins. Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373 [TBL] [Abstract][Full Text] [Related]
28. Differential expression of microRNA-210 in gliomas of variable cell origin and correlation between increased expression levels and disease progression in astrocytic tumours. Lai N; Zhu H; Chen Y; Zhang S; Zhao X; Lin Y Folia Neuropathol; 2014; 52(1):79-85. PubMed ID: 24729345 [TBL] [Abstract][Full Text] [Related]
29. MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells. Chen W; Yang Y; Chen B; Lu P; Zhan L; Yu Q; Cao K; Li Q J Neurooncol; 2014 Oct; 120(1):43-53. PubMed ID: 25139024 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-520c inhibits glioma cell migration and invasion by the suppression of transforming growth factor-β receptor type 2. Hu S; Chen H; Zhang Y; Wang C; Liu K; Wang H; Luo J Oncol Rep; 2017 Mar; 37(3):1691-1697. PubMed ID: 28184932 [TBL] [Abstract][Full Text] [Related]
31. Reduced expression of miR-3653 in glioma and its correlations with clinical progression and patient survival. Chen Y; Li ZH; Liu X; Liu GX; Yang HM; Wu PF Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6596-6601. PubMed ID: 31378901 [TBL] [Abstract][Full Text] [Related]
32. Upregulation of miR-132 expression in glioma and its clinical significance. Liu Q; Liao F; Wu H; Cai T; Yang L; Wang ZF; Zou R Tumour Biol; 2014 Dec; 35(12):12299-304. PubMed ID: 25234714 [TBL] [Abstract][Full Text] [Related]
33. cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome. Odia Y; Orr BA; Bell WR; Eberhart CG; Rodriguez FJ J Neurooncol; 2013 Nov; 115(2):249-59. PubMed ID: 23934175 [TBL] [Abstract][Full Text] [Related]
34. Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade. Huang RQ; Shi DL; Huang W; Chen F; Lu YC J Neurooncol; 2016 Apr; 127(2):235-42. PubMed ID: 26725095 [TBL] [Abstract][Full Text] [Related]
35. MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas. Hermansen SK; Dahlrot RH; Nielsen BS; Hansen S; Kristensen BW J Neurooncol; 2013 Jan; 111(1):71-81. PubMed ID: 23104517 [TBL] [Abstract][Full Text] [Related]
36. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma. Li B; Wang Y; Li S; He H; Sun F; Wang C; Lu Y; Wang X; Tao B Int J Clin Exp Pathol; 2015; 8(6):7016-21. PubMed ID: 26261592 [TBL] [Abstract][Full Text] [Related]
37. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Guessous F; Zhang Y; Kofman A; Catania A; Li Y; Schiff D; Purow B; Abounader R Cell Cycle; 2010 Mar; 9(6):1031-6. PubMed ID: 20190569 [TBL] [Abstract][Full Text] [Related]
38. Increased expression of microRNA-17 predicts poor prognosis in human glioma. Lu S; Wang S; Geng S; Ma S; Liang Z; Jiao B J Biomed Biotechnol; 2012; 2012():970761. PubMed ID: 23226946 [TBL] [Abstract][Full Text] [Related]
39. Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance. Wang L; Wu L; Wu J J Int Med Res; 2016 Oct; 44(5):994-1001. PubMed ID: 27417886 [TBL] [Abstract][Full Text] [Related]
40. HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Zhang JX; Han L; Bao ZS; Wang YY; Chen LY; Yan W; Yu SZ; Pu PY; Liu N; You YP; Jiang T; Kang CS; Neuro Oncol; 2013 Dec; 15(12):1595-603. PubMed ID: 24203894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]